Treatment of melasma with the 1,927-nm fractional thulium fiber laser: A retrospective analysis of 20 cases with long-term follow-up

Lasers in Surgery and Medicine

Volumn 45, Issue 2, 2013, Pages 95-101

  Niwa Massaki, Ane Beatriz M ^a   Eimpunth, Sasima ^a,b   Fabi, Sabrina G ^a   Guiha, Isabella ^a   Groff, William ^a   Fitzpatrick, Richard ^a  

^a Groff and Fabi Cosmetic Laser Dermatology   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

fractional laser; melasma; thulium laser

Indexed keywords

THULIUM;

ADULT; ARTICLE; BLEACHING; BODY SURFACE; CHLOASMA; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; LOW LEVEL LASER THERAPY; POSTINFLAMMATORY HYPERPIGMENTATION; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; TOPICAL TREATMENT;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASERS, SOLID-STATE; MELANOSIS; MIDDLE AGED; PATIENT SATISFACTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84874455153     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.22100     Document Type: Article

References (37)

1. Gupta AK, Gover MD, Nouri K, Taylor S,. Treatment of melasma: A review of clinical trial. J Am Acad Dermatol 2006; 55: 1048-1065.
2. Grimes PE,. Melasma: Etiologic and therapeutic considerations. Arch Dermatol 1995; 131: 1453-1457.
3. Im S, Kim J, On WY, Kang WH,. Increased expression of α-melanocyte-stimulating hormone in the lesional skin of melasma. Br J Dermatol 2007; 146: 165-167.
4. Kang HY, Hwang JS, Lee JY, Ahn JH, Kim JY, Lee ES, Kang WH,. The dermal stem cell factor and c-kit are overexpressed in melasma. Br J Dermatol 2006; 154: 1094-1099.
5. Abu Ubeid A, Zhao L, Wang Y, Hantash BM,. Short-sequence oligopeptides with inhibitory activity against mushroom and human tyrosinase. J Invest Dermatol 2009; 129 (9): 2242-2249.
6. Manaloto RM, Alster T,. Erbium: YAG laser resurfacing for refractory melasma. Dermatol Surg 1999; 25: 121-123.
7. 2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: Split-face design. Dermatol Surg 2003; 29: 59-64.
8. Rahman Z, Alam M, Dover JS,. Fractional laser treatment for pigmentation and texture improvement. Skin Therapy Lett 2006; 11: 7-11.
9. Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR,. Fractional photothermolysis: A new concept for cutaneous remodeling using microscopic patterns of thermal injury. Laser Surg Med 2004; 34: 426-438.
10. Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, Voorhees JJ,. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol 1994; 130: 727-733.
11. Balkrishnan R, McMichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S, Feldman SR, Chren MM,. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 2003; 149: 572-577.
12. Cestari TF, Hexsel D, Viegas ML, Azulay L, Hassun K, Almeida AR, Rêgo VR, Mendes AM, Filho JW, Junqueira H,. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: The MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. Br J Dermatol 2007; 156 (Suppl. 1): 13-20.
13. Freitag FM, Cestari TF, Leopoldo LR, Paludo P, Boza JC,. Effect of melasma on quality of life in a sample of women living in southern Brazil. J Eur Acad Dermatol Venereol 2008; 22: 655-662.
14. Haddad AL, Matos LF, Brunstein F, Ferreira LM, Silva A, Costa D, Jr., A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol 2003; 42: 153-156.
15. Neering H,. Treatment of melasma (chloasma) by local application of a steroid cream. Dermatologica 1975; 151: 349-353.
16. Griffiths CE, Finkel LJ, Ditre CM, Hamilton TA, Ellis CN, Voorhees JJ,. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. Br J Dermatol 1993; 129: 415-421.
17. Cestari TF, Hassun K, Sittart A, de Lourdes Viegas M,. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. J Cosmet Dermatol 2007; 6: 36-39.
18. Sarkar R, Kaur C, Bhalla M, Kanwar AJ,. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: A comparative study. Dermatol Surg 2002; 28: 828-832.
19. Khunger N, Sarkar R, Jain RK,. Tretinoin peels versus glycolic acid peels in the treatment of melasma in dark skinned patients. Dermatol Surg 2004; 30: 756-760.
20. Kunachak S, Leelaudomlipi P, Wongwaisayawan S,. Dermabrasion: A curative treatment for melasma. Aesthetic Plast Surg 2001; 25: 114-117.
21. Wang CC, Hui CY, Sue YM, Wong WR, Hong HS,. Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol Surg 2004; 30: 1196-1200.
22. 2 laser followed by Q-switched Alexandrite laser: A pilot study. Dermatol Surg 1999; 25: 494-497.
23. Wanitphakdeedecha R, Manuskiatti W, Siriphukpong S, Chen TM,. Treatment of melasma using variable square pulse Er:YAG laser resurfacing. Dermatol Surg 2009; 35 (3): 475-481; discussion 481-482.
24. Taylor CR, Anderson RR,. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol 1994; 20: 592-597.
25. Sheth VM, Pandya AG,. Melasma: A comprehensive update Part II. J Am Acad Dermatol 2011; 65 (4): 699-714; quiz 715. Review.
26. Prignano F, Ortonne JP, Buggiani G, Lotti T,. Therapeutical approaches in melasma. Dermatol Clin 2007; 25: 337-342.
27. Anderson RR, Parrish JA,. Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220: 524-527.
28. Alster TS, Lupton JR,. Laser therapy for cutaneous hyperpigmentation and pigmented lesions. Dermatol Ther 2001; 14: 46-54.
29. Wattanakrai P, Mornchan R, Eimpunth S,. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg 2010; 36: 76-87.
30. Manaloto RM, Alster TS,. Erbium: YAG laser resurfacing for refractory melasma. Dermatol Surg 1999; 25: 121-123.
31. Goldberg DJ, Berlin AL, Phelps R,. Histologic and ultrastructural analysis of melasma after fractional resurfacing. Lasers Surg Med 2008; 40: 134-138.
32. Rokhsar CK, Fitzpatrick RE,. The treatment of melasma with fractional resurfacing: A pilot study. Dermatol Surg 2005; 31: 1645-1650.
33. Katz TM, Glaich AS, Goldberg LH, Firoz BF, Dai T, Friedman PM,. Treatment of melasma using fractional photothermolysis: A report of eight cases with long-term follow-up. Dermatol Surg 2010; 36 (8): 1273-1280.
34. Karsai S, Fischer T, Pohl L, Schmitt L, Buhck H, Jünger M, Raulin C,. Is non-ablative 1550-nm fractional photothermolysis an effective modality to treat melasma? Results from a prospective controlled single-blinded trial in 51 patients. J Eur Acad Dermatol Venereol 2012; 26 (4): 470-476.
35. Lee HS, Won CH, Lee DH, An JS, Chang HW, Lee JH, Kim KH, Cho S, Chung JH,. Treatment of melasma in Asian skin using a fractional 1,550-nm laser: An open clinical study. Dermatol Surg 2009; 35 (10): 1499-1504.
36. Polder KD, Harrison A, Eubanks LE, Bruce S,. 1927-nm fractional thulium fiber laser for the treatment of nonfacial photodamage: A pilot study. Dermatol Surg 2011; 37 (3): 342-348.
37. Chen B, Thomsen SL, Thomas RJ, Oliver J, Welch AJ,. Histological and modeling study of skin thermal injury to 2.0 microm laser irradiation. Lasers Surg Med 2008; 40 (5): 358-370.